Metformin Therapies for Diabetes - Evidence Strength

Ver informe de evidencia

Evidence on outcomes studied for Metformin

Evidence related to metformin therapies in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

Studies

Evidence Pairs

Moderate Evidence

Evidence Strength: 61/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Metformin evidence appears to center on Glucose iAUC (OGTT).

Among 32 indexed studies and 3 interventions, the strongest signals are summarized from the available evidence. HbA1c has been studied often, while Glucose iAUC (OGTT) appears to have stronger current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Glucose iAUC (OGTT) appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 9 evidence pairs - 21 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsGenerally consistent

Glucose iAUC (OGTT)

6 studies

EvidenceScore™

83/100

ConsistencyScore™

36/100

Fasting Plasma Glucose (FPG)

7 studies

EvidenceScore™

84/100

ConsistencyScore™

59/100

Evidence Snapshot

Studies

Interventions

Outcomes

Across 3 studies, Metformin shows a moderate positive signal for BMI.

3 studies

EvidenceScore™: 79/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

HbA1c is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

HbA1c

Fasting Plasma Glucose (FPG)

HbA1c

13 studies

EvidenceScore™

85/100

ConsistencyScore™

68/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 11 evidence pairs - 22 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Total daily insulin dose may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Total daily insulin dose

Insulin sensitivity

Total daily insulin dose

3 studies

EvidenceScore™

79/100

ConsistencyScore™

67/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength

Evidence basis: 5 evidence pairs - 9 studies

View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

What outcomes has Metformin been studied for?

outcomes studied

Emerging Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Glucose iAUC (OGTT) are among the most studied areas in relation to Metformin.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.4 | strong positive | ConsistencyScore™ Generally Consistent | 13 studies
2
Fasting Plasma Glucose (FPG)
EvidenceScore™ Strong | EvidenceScore™ 83.9 | moderate positive | ConsistencyScore™ Generally Consistent | 7 studies
3
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 82.8 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

Does Metformin improve HbA1c?

intervention outcome_effect

Strong Evidence

Metformin appears to improve HbA1c.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.4 | strong positive | ConsistencyScore™ Generally Consistent | 13 studies

Why this answer: This answer is based on 13 supporting studies with generally consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Which outcomes have the strongest evidence for Metformin?

evidence strength

Strong Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Glucose iAUC (OGTT) have the strongest available evidence signals for Metformin.

ConsistencyScore™: Results are generally consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.4 | strong positive | ConsistencyScore™ Generally Consistent | 13 studies
2
Fasting Plasma Glucose (FPG)
EvidenceScore™ Strong | EvidenceScore™ 83.9 | moderate positive | ConsistencyScore™ Generally Consistent | 7 studies
3
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 82.8 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

Where does Metformin need more research?

research gaps

Moderate Evidence

Proportion achieving HbA1c <7.0%, Waist circumference, and Triglycerides need more research in relation to Metformin.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Insulin sensitivity
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
2
Waist circumference
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
3
Proportion achieving HbA1c <7.0%
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

How does Metformin compare across studied outcomes?

cross outcome_comparison

Strong Evidence

HbA1c, Fasting Plasma Glucose (FPG), and Glucose iAUC (OGTT) have available evidence for Metformin, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are generally consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.4 | strong positive | ConsistencyScore™ Generally Consistent | 13 studies
2
Fasting Plasma Glucose (FPG)
EvidenceScore™ Strong | EvidenceScore™ 83.9 | moderate positive | ConsistencyScore™ Generally Consistent | 7 studies
3
Glucose iAUC (OGTT)
EvidenceScore™ Strong | EvidenceScore™ 82.8 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations